Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether cognitive behavioural therapy can help people with Premature Infant, Mental Health Issue, Development, Child, or Parent-Child Relations. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
This study is looking at how a digital support tool works for people with Depression, Anxiety, Grief, Leadership, or Dissatisfaction in routine care. Participants receive advice and support from a mental health professional about oral health and daily oral hygiene.
This study is looking at whether Visbiome can help people with Depression. Participants take part in Visbiome and complete follow-up assessments.
This study is comparing Lorazepam with placebo for people with depression or anxiety. Participants receive Lorazepam or placebo and complete study visits and assessments.
This study is looking at whether Demographic Matching can help people with Depression or Anxiety. Participants take part in Demographic Matching and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing ARTEMIS with Waitlist Control (WLC) for people with Stimulant Use, Human Immunodeficiency Virus, or Depression. Participants receive ARTEMIS or Waitlist Control (WLC) and complete study visits and assessments.
This study is comparing Walk-and-talk therapy with Waitlist control for people with depression or anxiety. Participants receive Walk-and-talk therapy or Waitlist control and complete study visits and assessments.
This study is looking at whether ReStoreD can help people with Stroke, Depression, Anxiety, Coping Skills, or Couples. Participants take part in ReStoreD and complete follow-up assessments.
This study is looking at care and outcomes for people with Chronic Pain or Depression. Taking part may give some people access to Ketamine, but direct benefit is not guaranteed.
This study is comparing Low Dose Psilocybin with placebo for people with depression. Participants receive Low Dose Psilocybin or placebo and complete study visits and assessments.
This study is comparing Psilocybin with Control for people with Major Depression. Participants receive Psilocybin or Control and complete study visits and assessments.
This study is looking at whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy for people with Parkinson Disease or Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Psilocybin with placebo for people with depression or Alcohol Use Disorder. Participants receive Psilocybin or placebo and complete study visits and assessments.
This study is comparing Psilocybin with placebo for people with depression. Participants receive Psilocybin or placebo and complete study visits and assessments.
This study is looking at also assess whether psilocybin may improve quality of life in those individuals for people with Depressive Symptoms, Depression, Alzheimer Disease, or Mild Cognitive Impairment. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Psilocybin 25 mg with placebo for people with major depression. Participants receive Psilocybin 25 mg or placebo and complete study visits and assessments.
This study is looking at evaluate the efficacy of psilocybin on the symptom of anhedonia in individuals with treatment-resistant major depressive disorder for people with depression, Anhedonia, or Treatment Resistant Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether a digital support tool can help people with Chronic Low-back Pain or Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Psilocybin with Full dose COMP360 with sham aiTBS rTMS for people with Treatment Resistant Depression, Mdd, depression, or Recurrent Depression. Participants receive Psilocybin or Full dose COMP360 with sham aiTBS rTMS and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Spinal Cord Injury, Depression - depression, or Veteran. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Psilocybin can help people with Depression, Anxiety, Psilocybin-Assisted Psychotherapy, or Advanced Cancer. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Psilocybin can help people with Psychological Stress, Depression, or Anxiety. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Lung Non-Small Cell Carcinoma or Unipolar Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Refractory Depression or Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.